Bio
Marco Viganò received the Master’s Degree in Biology in 2011 and the Doctoral degree (PhD) in Life Sciences in 2017, both from Università degli Studi di Milano-Bicocca, Milan, Italy. Since 2011, he is working as a researcher in the Orthopaedic Biotechnology Lab, where he also completed his doctoral thesis. He is involved in many studies investigating the use of Mesenchymal Stem/Stromal Cells for Regenerative Medicine applications to the treatment of cartilage and tendon disorders. In 2017, he spent 6 months as Visitor Research Scholar at the Albert Einstein College of Medicine in New York, under the supervision of Prof. Laura Santambrogio, performing proteomics analysis of articular tissues. His main research interest is the development of innovative diagnostic and therapeutic solutions for unsolved clinical issues.
Publications
Cauci S, Viganò M, de Girolamo L, De Luca P, Perucca Orfei C, Banfi G, Lombardi G, Brayda-Bruno M, Colombini A. High Levels of Circulating Type II Collagen Degradation Marker (CTx-II) Are Associated with Specific VDR Polymorphisms in Patients with Adult Vertebral Osteochondrosis. Int J Mol Sci 2017 Sep 29; 18(10), 2073.
Brayda-Bruno, M., Viganò, M., Cauci, S., Vitale, J.A., de Girolamo, L., De Luca, P., Lombardi, G., Banfi, G., Colombini, A. Plasma vitamin D and osteo-cartilaginous markers in Italian males affected by intervertebral disc degeneration: Focus on seasonal and pathological trend of type II collagen degradation. Clinica Chimica Acta. 2017 Aug; 471:87-93
Perteghella S, Martella E, de Girolamo L, Perucca Orfei C, Pierini M, Fumagalli V, Pintacuda DV, Chlapanidas T, Viganò M, Faragò S, Torre ML, Lucarelli E. Fabrication of Innovative Silk/Alginate Microcarriers for Mesenchymal Stem Cell Delivery and Tissue Regeneration. Int J Mol Sci. 2017 Aug; 23;18(9).
Usuelli FG, Grassi M, Maccario C, Viganò M, Lanfranchi L, Alfieri Montrasio U, de Girolamo L. Intratendinous adipose-derived stromal vascular fraction (SVF) injection provides a safe, efficacious treatment for Achilles tendinopathy: results of a randomized controlled clinical trial at a 6-month follow-up. KSSTA 2017 Mar 1; Epub Ahead of Print.
Viganò M, Sansone V, d’Agostino MC, Romeo P, Perucca Orfei C, de Girolamo L. Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders. J Orthop Surg Res. 2016 Dec; 11: 163.
Perucca Orfei C, Lovati AB, Viganò M, Stanco D, Bottagisio M, Di Giancamillo A, Setti S, De Girolamo L. Dose-related and time-dependent development of collagenase-induced tendinopathy in rats. PLoS ONE. 2016 Aug; 11(8):e0161590.
Stanco D, Viganò M, Perucca Orfei C, Di Giancamillo A, Peretti GM, Lanfranchi L, de Girolamo L. Multidifferentiation potential of human mesenchymal stem cells from adipose tissue and hamstring tendons for musculoskeletal cell-based therapy. Regen Med. 2015 Jan; 7:1-15.
de Girolamo L, Viganò M, Galliera E, Stanco D, Setti S, Marazzi MG, Thiebat G, Corsi Romanelli MM, Sansone V. In vitro functional response of human tendon cells to different dosages of low-frequency pulsed electromagnetic field. Knee Surg Sports Traumatol Arthrosc. 2015 Nov; 23(11):3443-53
de Girolamo L, Stanco D, Galliera Emanuela, Viganò M, Lovati A, Marazzi MG, Romeo P, Sansone V. Soft focused extracorporeal shock waves increase the expression of tendon specific markers and the release of anti-inflammatory cytokines in an adherent culture model of primary human tendon cells. Ultrasound Med Biol. 2014 Jun; 40(6):1204-15
de Girolamo L, Stanco D, Galliera E, Viganò M, Colombini A, Setti S, Vianello E, Corsi Romanelli MM, Sansone V. Low Frequency Pulsed Electromagnetic Field Affects Proliferation, Tissue-Specific Gene Expression, and Cytokines Release of Human Tendon Cells. Cell Biochem Biophys. 2013 Jul; 66(3):697-708